Altogether our data indicate that the active chromatin landscape in PAH patients is specifically altered at enhancers that regulate genes involved in smooth muscle cell differentiation and may respond aberrantly to TGFβ signaling. The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.